Dr. Al-Yafeai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1740 W Taylor St
Chicago, IL 60612Phone+1 866-600-2273
Education & Training
LSU Health Sciences Center-ShreveportPhD, Molecular and Cellular Physiology, 2015 - 2020
Jordan University of Science and Technology FOMClass of 2014, MD
Certifications & Licensure
IL State Medical License 2023 - 2026
LA State Medical License 2020 - 2023
Awards, Honors, & Recognition
- Predoctoral Fellowship American Heart Association, 2018-2020
Publications & Presentations
PubMed
- 7 citationsCardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users: Geographical and Social Disparities.Zaki Al-Yafeai, Shafaqat Ali, Jimmy Brown, Maamannan Venkataraj, Md Shenuarin Bhuiyan
JACC. Advances. 2024-07-01 - 2 citationsNovel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).Zaki Al-Yafeai, Manush Sondhi, Kavya Vadlamudi, Rahul Vyas, Daniyal Nadeem
International Journal of Cardiology. 2024-05-01 - 1 citationsTrends in peripheral artery disease and critical limb ischemia hospitalizations among cocaine and methamphetamine users in the United States: a nationwide study.Shafaqat Ali, Zaki Al-Yafeai, Md Ismail Hossain, Md Shenuarin Bhuiyan, Sanchit Duhan
Frontiers in Cardiovascular Medicine. 2024-01-01
Press Mentions
US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth UsersMarch 19th, 2024
Grant Support
- Integrin Affinity Modulation of AtheroscerlosisAmerican Heart AssociationPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
